跳至主要内容
临床试验/IRCT20191111045407N1
IRCT20191111045407N1尚未招募2 期

Comparison of Citalopram and Pramipexole treatments on depression in Parkinson disease

Esfahan University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 80 years(—)
性别
All

入选标准

  • Controlled disease with monotheraphy with Levodopa

排除标准

  • Cognitive disorders
  • Psychotic disorders and suicidal thought or attempt
  • Use of antipsychotics, anticholinergics, dopamine agonists and other psychological drugs and therapies
  • Use of metoclopramide, methyldopa, methylphenidate, reserpine, flunarizine, Cinnarizine and amphetamine derivatives within the past 3 months
  • History of malignant melanoma
  • History of previous deep brain stimulation surgery
  • using contraceptive drugs
  • Off” period for greater than 50% of the day

研究者

相似试验